XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

Stock Information for XOMA Royalty Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About XOMA Royalty Corporation

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
XOMA Royalty Declares Quarterly Preferred Stock Dividends
XOMA Royalty Enters into Agreement to Acquire Generation Bio
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.